WALE WATCH

Stocks closed deeply in the red after painful selling. President Trump’s temporary relief for USMCA-covered items was not enough to stop the selling. The VIX index rose reflecting the growing volatility related to trade uncertainty. Bitcoin closed below 90,000 despite continued vocal support for a crypto reserve.

‍

($AVAV) AeroVironment

‍

AeroVironment (AVAV) reported disappointing Q3 FY2025 results on March 4, with revenue declining 10% year-over-year to $167.6 million and earnings per share of $0.30, significantly missing analyst estimates of $0.58. The company's stock price dropped sharply following the earnings release, falling as much as 22.4% at one point. In response to the weak quarter, several analysts lowered their price targets for AVAV, including Jefferies reducing its target from $230 to $190 while maintaining a "Buy" rating.

($HPK) HPK

HighPeak Energy (HPK) announced it will release its Q4 and full-year 2024 financial results after market close on March 10, 2025, with a conference call scheduled for March 11. The company's stock price target is$19.17 according to analysts, with estimates ranging from $11.00 to $31.50. No other significant stock-moving news for HPK was reported in the past week based on the provided search results.

($SLP) SLP

Simulations Plus (SLP) reported Q1 2025 earnings of $0.17per share on January 7, missing analyst estimates of $0.18 per share, though revenues of $18.92 million beat expectations. On January 8, Keybanc lowered their price target on SLP from $40 to $35 while maintaining an Overweight rating. Despite the earnings miss, SLP shares have added about 4.3% since the beginning of the year, outperforming the S&P 500's 1.6% gain over the same period.

($VTLE) VTLE

Vital Energy (VTLE) reported Q4 2024 earnings of $2.30 per share on February 19, 2025, beating analyst estimates of $2.03. Piper Sandler lowered its price target on VTLE to $24 from $32 on March 6, 2025, citing concerns about the company's outlook for FY25. SWS Research downgraded Vital Energy to Hold from Buy on March 5, 2025, with a price target of $62.

($VTS) VTS

Vitesse Energy (VTS) is expected to report quarterly earnings on March 11, 2025, with analysts projecting earnings of $0.26 per share, down 50% year-over-year, on revenues of $59.27 million, a 14.5% decline. The stock has a consensus "Buy" rating from analysts, with an average price target of $30, implying nearly 18% upside from current levels. Broader economic concerns around inflation, tariffs, and slowing growth could impact the energy sector and VTS stock in the near-term.

($GENK) GENK

GEN Restaurant Group (GENK) reported Q4 2024 earnings on March 6, 2025, with revenue of $54.7 million beating estimates but EPS of-$0.04 missing expectations. The company announced plans to open 10-13 new locations in 2025, including expansion into South Korea. GENK maintains a consensus "Strong Buy" rating from analysts, with an average price target of $13.17 implying significant upside potential.

($LOVE) LOVE

Lovesac (LOVE) reported Q3 2025 earnings on December 12,2024, with an EPS of -$0.32 beating estimates of -$0.34, though revenue of$149.90 million missed expectations of $155.26 million. DA Davidson maintained a Buy rating on LOVE but lowered the price target from $44 to $35 on December13, 2024. The stock has declined over 7% in the past week amid broader market weakness and concerns about consumer spending.

($RICK) RICK

RCI Hospitality (RICK) reported Q1 2025 earnings of $1.01per share, beating estimates by $0.49, with revenue of $71.48 million. The company declared its 37th consecutive quarterly cash dividend of $0.07 per share for Q2 2025, payable on March 31, 2025. HC Wainwright & Co. reiterated their buy rating for RICK with a $98 price target on February 12,2025, implying significant upside potential.

($AGEN) AGEN

Agenus (AGEN) reported Q1 2024 results, announcing a $100million royalty financing agreement with Ligand to support development of its lead program BOT/BAL in colorectal cancer. The company successfully executed a 20:1 reverse stock split during Q1 2024 to regain Nasdaq compliance and enable investment by certain institutional investors. Agenus ended Q1 2024 with $52.9million in cash and cash equivalents, compared to $76.1 million at the end of2023.

($AIRS) AIRS

AirSculpt Technologies (AIRS) is expected to report its quarterly earnings on March 11, 2025, with analysts estimating revenue of$44.25 million and earnings per share of -$0.04. The company's stock has declined 23.9% year-to-date, currently trading at $3.95. Analysts maintain a consensus "Hold" rating on AIRS stock, with a price target of $5.00,representing a potential 21.95% upside from current levels.

‍